715 filings
Page 2 of 36
8-K
l9itk
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
424B4
ffodci
9 Feb 24
Prospectus supplement with pricing info
5:00pm
424B3
yahl 3w97y
8 Feb 24
Prospectus supplement
4:51pm
EFFECT
8qrd18mobf
8 Feb 24
Notice of effectiveness
12:15am
8-K
1263mag6oj7
8 Feb 24
Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study
12:00am
424B3
i15jvoqr6ei3gao28jy
6 Feb 24
Prospectus supplement
9:20am
8-K
rzbostd mph13l
6 Feb 24
Other Events
8:56am
CORRESP
lha0no
5 Feb 24
Correspondence with SEC
12:00am
CORRESP
7g61jvucfd9s31
5 Feb 24
Correspondence with SEC
12:00am
CORRESP
wends8
1 Feb 24
Correspondence with SEC
12:00am
424B3
p5dfrls9bf ed
22 Jan 24
Prospectus supplement
4:30pm
8-K
pat7i mbhk
19 Jan 24
Other Events
4:30pm
424B3
6lckt6sngunsv0ziy
16 Jan 24
Prospectus supplement
4:31pm
3
i3l5 3uvljf6
12 Jan 24
TENAX THERAPEUTICS / LAWRENCE R HOFFMAN ownership change
5:46pm
8-K
8autd
12 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
424B3
qjj6b8acm6igu 5c4
9 Jan 24
Prospectus supplement
4:31pm
8-K
c0b5ert vw5
5 Jan 24
Tenax Therapeutics Announces Reverse Stock Split
4:46pm
UPLOAD
oqbx8gg6d2lqppelgsvw
7 Dec 23
Letter from SEC
12:00am